0 NASDAQ Companies - June 27, 2019Dova Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for DOPTELET® (avatrombopag) for Treatment of Chronic Immune Thrombocytopenia (ITP)Read More
0 Canadian Stock Exchange News - June 27, 2019CROP Investment Holding World Farms Corp. Announces Definitive Agreement to go Public on the CSERead More
0 Canadian Stock Exchange News - June 27, 2019Black Tusk Resources Inc. Selects ALS Geochemistry for the Golden Valley Project, QuebecRead More
0 NYSE Companies - June 27, 2019Mizuho Expands its Technology Practice with the Addition of Equity Research Analyst, Siti PanigrahiRead More
0 NYSE Companies - June 27, 2019Grace to Release Second Quarter 2019 Results on July 25, 2019Read More
0 NASDAQ Companies - June 27, 2019Pacific Mercantile Bank Provides $3.0 Million in Financing to Brand Value AcceleratorRead More
0 NASDAQ Companies - June 27, 2019Wave Life Sciences Announces Initiation of DYSTANCE 51, a Phase 2/3 Clinical Trial of SuvodirsenRead More
0 NASDAQ Companies - June 27, 2019SI-BONE’s iFuse Implant System Surpasses 40,000 ProceduresRead More
0 NASDAQ Companies - June 27, 2019Atossa Genetics’ Preliminary Phase 2 Study Achieves Primary Endpoint: Topical Endoxifen Rapidly Reduces Breast DensityRead More
0 NASDAQ Companies - June 27, 2019Ovid Therapeutics Initiates Pivotal Phase 3 Clinical Trial in Angelman Syndrome; Multiple Data Readouts Across Rare Neurological Disease Pipeline Expected in 2H 2019 and Early 2020Read More
